With Professor Robert Clancy.
Link to Quadrant, https://quadrant.org.au/news-opinions/uncategorized/after-covid-now-its-the-lawyers-turn/
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up
https://www.medrxiv.org/content/10.1101/2024.11.13.24317190v1
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults
https://academic.oup.com/cid/article/78/5/1372/7450138
Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
https://www.nature.com/articles/s41467-024-45549-9
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
https://academic.oup.com/cid/article/75/11/1980/6570607
COVID-19 mRNA VACCINES: THE PROBLEM THAT WON’T GO AWAY.
Emeritus Professor Robert Clancy AM
Source